These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15026493)

  • 1. The L-dopa response in vascular parkinsonism.
    Zijlmans JC; Katzenschlager R; Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):545-7. PubMed ID: 15026493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
    Ohta K; Obara K
    Mov Disord; 2006 Jan; 21(1):124-5. PubMed ID: 16229001
    [No Abstract]   [Full Text] [Related]  

  • 4. Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism.
    Tohgi H; Takahashi S; Abe T; Utsugisawa K
    Eur Neurol; 2001; 46(1):1-10. PubMed ID: 11455176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular parkinsonism--an important cause of parkinsonism in older people.
    Thanvi B; Lo N; Robinson T
    Age Ageing; 2005 Mar; 34(2):114-9. PubMed ID: 15713855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T
    Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
    Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
    Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C; Guidi M
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
    Kivi A; Trottenberg T; Kupsch A; Plotkin M; Felix R; Niehaus L
    Mov Disord; 2005 Feb; 20(2):258-60. PubMed ID: 15551348
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopa-responsive parkinsonism secondary to right temporal lobe haemorrahage.
    Ling MJ; Aggarwal A; Morris JG
    Mov Disord; 2002 Mar; 17(2):402-4. PubMed ID: 11921132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular parkinsonism: what makes it different?
    Gupta D; Kuruvilla A
    Postgrad Med J; 2011 Dec; 87(1034):829-36. PubMed ID: 22121251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular pseudoparkinsonism.
    Chang CM; Yu YL; Ng HK; Leung SY; Fong KY
    Acta Neurol Scand; 1992 Dec; 86(6):588-92. PubMed ID: 1481645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.
    Zijlmans J; Booij J; Valk J; Lees A; Horstink M
    Mov Disord; 2002 Sep; 17(5):1086-8. PubMed ID: 12360565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
    Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are "on-off" effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway?
    Carlsson A
    J Neural Transm Suppl; 1983; 19():153-61. PubMed ID: 6321646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism.
    Rampello L; Alvano A; Battaglia G; Raffaele R; Vecchio I; Malaguarnera M
    J Neurol; 2005 Sep; 252(9):1045-9. PubMed ID: 15940389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.